SpyBiotech cashes in on Serum Institute deal, netting $32.5M round for its 'superglue' VLP vaccine tech
Roughly five months after partnering with the Serum Institute of India to develop Covid-19 vaccines, SpyBiotech is ready for its next big thing.
The British …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
